These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2685357)

  • 1. A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene.
    Feldman RA; Lowy DR; Vass WC; Velu TJ
    J Virol; 1989 Dec; 63(12):5469-74. PubMed ID: 2685357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective potentiation of c-fps/fes transforming activity by a phosphatase inhibitor.
    Feldman RA; Lowy DR; Vass WC
    Oncogene Res; 1990; 5(3):187-97. PubMed ID: 2157188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cellular fps/fes cDNA rescued via retroviral shuttle vector encodes myeloid cell NCP92 and has transforming potential.
    Feldman RA; Vass WC; Tambourin PE
    Oncogene Res; 1987; 1(4):441-58. PubMed ID: 3329718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice.
    Greer P; Maltby V; Rossant J; Bernstein A; Pawson T
    Mol Cell Biol; 1990 Jun; 10(6):2521-7. PubMed ID: 2188092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant feline sarcoma proviruses containing the viral oncogene (v-fes) and either feline or murine control elements.
    Even J; Anderson SJ; Hampe A; Galibert F; Lowy D; Khoury G; Sherr CJ
    J Virol; 1983 Mar; 45(3):1004-16. PubMed ID: 6300443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming potential of a human protooncogene (c-fps/fes) locus.
    Sodroski JG; Goh WC; Haseltine WA
    Proc Natl Acad Sci U S A; 1984 May; 81(10):3039-43. PubMed ID: 6328490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the gag and pol sequences to the leukemogenicity of Friend murine leukemia virus.
    Oliff A; McKinney MD; Agranovsky O
    J Virol; 1985 Jun; 54(3):864-8. PubMed ID: 3999195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human c-fps/fes gene product expressed ectopically in rat fibroblasts is nontransforming and has restrained protein-tyrosine kinase activity.
    Greer PA; Meckling-Hansen K; Pawson T
    Mol Cell Biol; 1988 Feb; 8(2):578-87. PubMed ID: 3352601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene.
    Di Marco E; Pierce JH; Knicley CL; Di Fiore PP
    Mol Cell Biol; 1990 Jun; 10(6):3247-52. PubMed ID: 1971420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the feline c-fes/fps proto-oncogene: genesis of a retroviral oncogene.
    Roebroek AJ; Schalken JA; Onnekink C; Bloemers HP; Van de Ven WJ
    J Virol; 1987 Jun; 61(6):2009-16. PubMed ID: 3553615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subgenomic fragment of molecular cloned Friend murine leukemia virus DNA contains the gene(s) responsible for Friend murine leukemia virus-induced disease.
    Oliff A; Linemeyer D; Ruscetti S; Lowe R; Lowy DR; Scolnick E
    J Virol; 1980 Sep; 35(3):924-36. PubMed ID: 6252347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming activity of the RL-akt gene, a c-akt gene activated by long terminal repeat insertion in murine leukemia RL(male symbol)1 cells.
    Tanino M; Matsuo M; Uenaka A; Tsukuda K; Ouchida M; Nakayama E; Shimizu K
    Mol Carcinog; 1999 Dec; 26(4):286-97. PubMed ID: 10569805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
    Feuer G; Fan H
    J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
    Hanecak R; Pattengale PK; Fan H
    J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regions of the Moloney murine leukemia virus genome specifically related to induction of promonocytic tumors.
    Wolff L; Koller R
    J Virol; 1990 Jan; 64(1):155-60. PubMed ID: 2403439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211.
    Masuda M; Remington MP; Hoffman PM; Ruscetti SK
    J Virol; 1992 May; 66(5):2798-806. PubMed ID: 1560524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
    Fan H; Mittal S; Chute H; Chao E; Pattengale PK
    J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeat.
    Brightman BK; Li QX; Trepp DJ; Fan H
    J Exp Med; 1991 Aug; 174(2):389-96. PubMed ID: 1856627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
    Brightman BK; Farmer C; Fan H
    J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.